Tokyo, Sept. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059039) titled 'Prospective observational study evaluating the clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with macular hole' on Sept. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu university school of medicine
Condition:
Condition - cataract and macular hole
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with macular hole
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - The patients who receive combined vitrectomy and cataract surgery in patients with macular hole.
Key exclusion criteria - The patients who have other diseases except for cataract and macular hole
Target Size - 80
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 09 Month 09 Day
Anticipated trial start date - 2025 Year 11 Month 05 Day
Last follow-up date - 2030 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067533
Disclaimer: Curated by HT Syndication.
